Introduction
============

Early diagnosis of primary intracranial tumors is important as some of them, eg, meningiomas, can be radically resected. Additionally, low-grade astrocytomas may transform into high-grade astrocytomas.[@b1-clep-10-809] More than half of the primary intracranial tumors among adults are malignant astrocytoma and meningioma.[@b2-clep-10-809] The prognosis varies from a 5-year survival of glioblastoma of \<5% to a 10-year survival of meningioma of 90%.[@b2-clep-10-809]

General practitioners (GPs) are often involved in the diagnosis, particularly in the very early phases of the disease.[@b3-clep-10-809],[@b4-clep-10-809] With approximately 1,500 primary intracranial tumor patients annually in Denmark,[@b5-clep-10-809] a Danish GP will on average see 1 patient with an intracranial tumor every third year. Identifying patients in general practice who are suspected of having a primary intracranial tumor is a difficult task as symptoms of cancer generally have low positive predictive values in general practice.[@b6-clep-10-809]

Primary intracranial tumors often present with specific focal neurological deficits, such as loss of motor function, sensory loss, abnormalities of the visual fields, or with new-onset seizure.[@b7-clep-10-809] Nevertheless, many symptoms of intracranial tumors are vague and nonspecific, such as headache, nausea, dizziness, confusion, anxiety, depression, fatigue, and memory loss; these are symptoms that mostly are caused by other conditions apart from intracranial tumors.[@b8-clep-10-809] All symptoms of brain tumors, except new-onset epilepsy, are individually linked with low risk in general practice.[@b7-clep-10-809] Thus, primary intracranial tumors possess important features seen with prolonged cancer diagnostics in general: low incidence and uncharacteristic symptoms.[@b9-clep-10-809] Delayed diagnosis may have important consequences for the patients in terms of higher mortality and morbidity and more advanced stages of disease at treatment initiation.[@b10-clep-10-809]

Although increased health care use can be a proxy for symptom presentation and how health care professionals act on this symptom presentation,[@b11-clep-10-809] little is known about how and when adults seek health care before a primary intracranial tumor diagnosis. The sparse evidence indicates that a high proportion of patients with a brain tumor has multiple primary care consultations before referral[@b12-clep-10-809] and that children and young patients with central nervous system (CNS) tumors have elevated health care use from 17 months prior to diagnosis.[@b11-clep-10-809]

We aimed to investigate the health care use among adults during the 2 years preceding a diagnosis of a benign or a malignant primary intracranial tumor in Denmark.

Methods
=======

We performed a population-based matched comparative study using national registry data. Data was linked at the individual level by using the Danish civil registration number assigned to all Danish citizens.[@b13-clep-10-809]

Setting
-------

The publicly funded health care system in Demark provides free access for all citizens to general practice and hospital care, and nearly all citizens (98%) are registered with a GP.[@b14-clep-10-809] The GPs are gatekeepers to the rest of the health care system as they carry out initial diagnostic investigations and refer patients to hospitals or outpatient clinics if needed.[@b15-clep-10-809] Patients may, however, contact an ear--nose--throat (ENT) specialist or an ophthalmologist without referral from a GP.[@b15-clep-10-809]

Study population
----------------

Patients were identified in the Danish Cancer Registry[@b16-clep-10-809] and were eligible if diagnosed with a first-time primary intracranial tumor, benign (International Classification of Diseases, 10th revision \[ICD-10\][@b17-clep-10-809]: D320, D330-332, D333B, D333A, D352\*, D353, D354) or malignant (ICD-10: C722, C723, C724, C725, C751, C752, C753, C700, C71\*), from January 1, 2009 to December 31, 2014, and aged 30--90 years at the date of diagnosis. In total, 6,956 patients were identified.

We excluded 1,030 (14.8%) patients: 822 (11.8%) due to a previous or concurrent cancer (previous nonmelanoma skin cancer \[C44\] did not result in exclusion), 30 (0.4%) due to no registration at Statistics Denmark, 94 (1.4%) who lived outside Denmark at some point during the 24 months preceding diagnosis, and 84 (1.2%) who were not listed with a general practice.

The study was approved by the Danish Data Protection Agency (file no. 2009-41-3471). According to Danish law, the study did not require approval from the Committee on Health Research Ethics of the Central Denmark Region as no biomedical intervention was performed.

Comparison subjects
-------------------

Using incidence density sampling, we identified 10 comparison subjects matched on age, gender, and listed general practice for each patient. Information about general practice affiliation was available from the Patient List Register, which holds information on persons assigned to a certain GP at any given time. The index date was defined as the date of the diagnosis of the corresponding patient.

Comparison subjects were not eligible if they fulfilled any of the above listed exclusion criteria for patients. The age difference between patient and the corresponding comparison subject exceeded 2 years for 489 (0.8%) comparison subjects. They were replaced by comparison subjects sampled among patients listed with random general practices in Denmark.

Outcomes
--------

The main outcomes of the study were daytime face-to-face consultations in general practice, including home visits, physiotherapy consultations, radiological examinations, and face-to-face contact with the following specialties: ENT, ophthalmology, neurology, and psychiatry, and all other hospital contacts.

For radiology contacts, we included all types of overall computed tomography, magnetic resonance, X-ray, and ultrasound scans made in primary or secondary care. This approach ensured that all examinations were counted regardless of the organizational place of the radiological examination, thus making it possible to compare patients with primary intracranial tumors with comparison subjects prior to diagnosis. Data regarding consultations in primary care were extracted from the Danish National Health Service Register,[@b18-clep-10-809] which holds information on all services provided by general practice, physiotherapists, private specialist doctors, and radiological examinations at private radiological clinics for the purpose of remuneration.

Data regarding contacts to somatic hospital (inpatient and outpatient contacts) and data on radiological examinations in secondary health care were extracted from the Danish National Patient Register (DNPR), which contains information on all in- and outpatient contacts at somatic hospitals in Denmark since 1977; outpatient contacts have been included in the register since 1995.[@b19-clep-10-809] Diagnostic information in DNPR is based on the ICD, 8th revision from 1977 to 1993, and the ICD-10 from 1994 to 2016.[@b19-clep-10-809] Information on psychiatric inpatient and outpatient contacts was retrieved from the Danish Psychiatric Central Research Register, which holds information on all patient contacts with psychiatric departments in Denmark.[@b20-clep-10-809]

To investigate the total consultation pattern across medical specialties, the measures of radiological examination, ENT, ophthalmology, neurology, and psychiatry represent the sum of contacts in both primary and secondary health care.

Covariates
----------

The covariates included were age, comorbidity, marital status, income, educational level, labor market affiliation, and country of origin. Additionally, information on known diseases within 4 medical specialties of interest (ENT, ophthalmology, neurology, and psychiatry) was used for subanalyses.

Age was defined as the age at the index date. To adjust for comorbidity, the Charlson Comorbidity Index (CCI) was calculated[@b21-clep-10-809] based on diagnoses registered in the DNPR 10 years prior to the study entry (2 years prior to the index date) and grouped into "None" (CCI score =0), "Moderate" (CCI score =1--2), and "Severe" (CCI score ≥3).

Demographic and socioeconomic information was collected from Statistics Denmark.[@b22-clep-10-809] Marital status was categorized into "Living alone" or "Married/Cohabitating." Data on taxable income was extracted for the calendar year preceding the index date to eliminate the risk of influence from the primary intracranial tumor diagnosis. Income was subdivided into 3 equally sized groups using the OECD-modified scale and classified as "Low," "Middle", or "High" income.[@b23-clep-10-809] The highest attained level of education was categorized into "Basic," "Short", and "Long" according to the International Standard Classification of Education.[@b24-clep-10-809] Labor market affiliation based on the main employment during the preceding 12 months was categorized into "Working," "Unemployed" (including maternity leave and unspecified leave), and "Retired" (including persons on early retirement and persons receiving early retirement benefit). Country of origin was categorized as "Danish" or "Immigrant."

Persons with missing information on marital status (n=1) were categorized as "Cohabiting." Persons with missing information on income (n=1) were categorized as "Low income." Persons with missing information on education (357 patients, 3,854 comparison subjects) were categorized as "Basic education," as these persons are most often uneducated.[@b25-clep-10-809] Persons with missing information on labor market affiliation (200 patients, 2,009 comparison subjects) were categorized as "Unemployed," as these persons most often have no income,[@b26-clep-10-809] and persons with missing information on nationality (n=1) were categorized as "Danish."

Data on known diseases within the 4 specific medical specialties ENT, ophthalmology, neurology, and psychiatry, were retrieved from the DNPR according to medical specialty-specific ICD-10 codes, except for diagnoses already accounted for in the CCI. The known diseases of interest were defined as ENT: "diseases in ear and mastoid process of temporal bone (DH60-DH95);" ophthalmology: "diseases in eye and orbital region (DH00-DH59);" neurology: "diseases in the nervous system (G00-G29, G31-G44, G46-G79, and G83-G99);" and psychiatry: "psychiatric disease and behavioral disorders (F03-F05.0 and F05.2-F99)."

Statistical analysis
--------------------

Analyses were stratified on whether patients were diagnosed with a benign or a malignant primary intracranial tumor. The analyses were performed for each sex separately because of known gender differences in the health care utilization.[@b27-clep-10-809]

Odds ratios (ORs) of having consultations in the year prior to diagnosis (omitting the last month before diagnosis) were estimated using conditional logistical regression to account for the matched design.

A negative binominal regression model applying cluster robust variance at the patient level was used to estimate incidence rate ratios (IRRs) for comparison of the monthly rates of health care contacts between patients and comparison subjects in the entire 2-year period before diagnosis.

Analyses were adjusted for age, comorbidity, marital status, income, educational level, labor market affiliation, and country of origin.

To investigate if known diseases within a medical specialty influenced the estimates, we undertook subanalyses on the ORs of having a consultation at ENT, ophthalmology, neurology, and psychiatry, by adjusting for the presence of known disease of the specific medical specialty in question (ie, the ORs of having a consultation in ophthalmology was also adjusted for known diseases in the eye and orbital region).

Data were analyzed using the statistical software Stata 14 (StataCorp LP, College Station, TX, USA).

Results
=======

The study included 5,926 incident first-time primary intra-cranial tumor patients and 59,260 comparison subjects. Of the patients identified 3,654 (62%) had a benign tumor (70% among women and 52% among men, respectively).

The patients and the comparison subjects were generally comparable, although more patients with benign tumors than their comparison subjects had comorbidity ([Table 1](#t1-clep-10-809){ref-type="table"}). The opposite trend was observed for patients with malignant tumors.

Patients with benign primary intracranial tumors
------------------------------------------------

In the year preceding diagnosis (omitting the last month before diagnosis), the proportion of female patients diagnosed with a benign tumor who consulted the different health care providers were as follows: GP: 91.1%, physiotherapy: 14.1%, radiology: 47.2%, ENT: 19.2%, ophthalmology: 24.0%, neurology: 7.4%, psychiatry: 3.6%, and other hospital contacts: 45.6% ([Table 2](#t2-clep-10-809){ref-type="table"}). The numbers were slightly lower for men.

Patients with benign tumors had higher odds of having 5--9 consultations in general practice than comparison subjects (both sexes), and female patients had higher odds of having ≥10 consultations in general practice than the comparison subjects ([Table 2](#t2-clep-10-809){ref-type="table"}).

Overall, female and male patients had higher likelihood of having 1 or more contacts to ophthalmology, ENT, and neurology than the comparison subjects ([Table 2](#t2-clep-10-809){ref-type="table"}). Female patients had a particularly higher likelihood of ≥3 neurology contacts than the comparison subjects, which was not seen for male patients. Additionally, both male and female patients had higher odds of having 1 or more radiology contacts than the comparison subjects.

Overall, patients with benign tumors had significantly more consultations than the comparison subjects 1--24 months prior to diagnosis peeking the last month prior to diagnosis ([Figures 1](#f1-clep-10-809){ref-type="fig"}, [3](#f3-clep-10-809){ref-type="fig"}, and [S1](#SD1-clep-10-809){ref-type="supplementary-material"}). The starting point of increased health care use differed between male and female patients, eg, for general practice (men: 11 months, women: 20 months) and neurology (men: 9 months, women: 21 months). Further, the starting point of increased health care use differed across specialties, eg, ENT (both men and women: 24 months).

The peak in consultations 2 months prior to diagnosis ranged from 36% more consultations for physiotherapy (IRR~women~=1.36 \[95% confidence interval \[CI\]: 1.08; 1.72\]) to 19 times more consultations within neurology (IRR~women~=9.61 \[95% CI: 15.83; 24.29\]) ([Figures 1](#f1-clep-10-809){ref-type="fig"} and [3](#f3-clep-10-809){ref-type="fig"}).

Patients with malignant primary intracranial tumors
---------------------------------------------------

In the year preceding diagnosis (omitting the last month before diagnosis), the proportion of female patients diagnosed with a malignant tumor who consulted the different health care providers were as follows: GP: 87.1%, physiotherapy: 13.5%, radiology: 39.0%, ENT: 14.2%, ophthalmology: 23.6%, neurology: 5.0%, psychiatry: 3.0%, and other hospital contacts: 34.7% ([Table 2](#t2-clep-10-809){ref-type="table"}). The numbers were slightly different for men.

The patients did not show higher likelihood of having consulted any of the health care professionals during the period 2--12 months prior to diagnosis than the comparison subjects, except for neurology consultations. Male patients had higher odds of having 1 or 2 consultations with a neurologist, and female patients had higher odds of having 3 or more consultations with a neurologist relative to their comparison subjects ([Table 2](#t2-clep-10-809){ref-type="table"}).

In general, patients with malignant tumors had significantly more consultations than the comparison subjects 1--7 months prior to diagnosis, peaking in the last month prior to diagnosis ([Figures 2](#f2-clep-10-809){ref-type="fig"}, [4](#f4-clep-10-809){ref-type="fig"}, and [S2](#SD2-clep-10-809){ref-type="supplementary-material"}). The starting point of increased health care use differed between male and female patients, eg, general practice (women: 4 months, men: 6 months) and neurology (women: 7 months, men: 5 months) and across medical specialties ([Figures 2](#f2-clep-10-809){ref-type="fig"}, [4](#f4-clep-10-809){ref-type="fig"}, and [S2](#SD2-clep-10-809){ref-type="supplementary-material"}).

The peak in consultations 2 months prior to diagnosis ranged from 61% more consultations with a GP (IRR ~women~=1.61 \[95% CI: 1.45; 1.79\]) to more than 16 times more neurology consultations (IRR ~women~=16.74 \[95% CI: 11.32; 24.75\]) ([Figures 2](#f2-clep-10-809){ref-type="fig"} and [4](#f4-clep-10-809){ref-type="fig"}).

Subanalyses
-----------

Overall, similar results were seen when adjusting for known specialty-specific disease ([Table S1](#SD3-clep-10-809){ref-type="supplementary-material"}), although the ORs of having 1--2 ophthalmology consultations for women with benign tumors and of having 1--2 neurology consultations for men with benign tumors were no longer significant.

Discussion
==========

Main findings
-------------

This study on data from almost 6,000 patients diagnosed with a primary intracranial tumor shows that patients diagnosed with benign and malignant primary intracranial tumors use health care differently in the time prior to diagnosis. Patients with malignant tumors had increased health care use in relatively close proximity to the diagnosis, whereas patients with benign tumors had increased health care use for a long time before diagnosis. Most notably, patients with benign tumors had increased health care use 24 months prior to diagnosis for ENT consultations, from 21 months prior to diagnosis for neurology consultations, and from 12 months prior to diagnosis for ophthalmology consultations.

Strengths and limitations
-------------------------

The strengths of this study include the population-based design, which was permitted by the uniformly organized health care system in Denmark, the use of the data from the complete Danish registries,[@b18-clep-10-809],[@b19-clep-10-809],[@b28-clep-10-809] and the identification of patients in the Danish Cancer Registry.[@b16-clep-10-809] The comparison subjects were randomly sampled by a density sampling procedure and thus should be representative of the source population concerning health care use.

Although we used the Danish Cancer Registry to identify patients, misclassification of tumors as either malignant or benign may still occur as the diagnosis may have been based solely on neuroimaging.[@b29-clep-10-809],[@b30-clep-10-809] However, such misclassification should result in an underestimation of the associations found. Some information on educational level and labor market affiliation was missing. The missing data was distributed equally between patients and comparison subjects, and inclusion of these data should not bias the results.

We minimized the risk of confounding by matching comparison subjects and patients according to gender, age, and general practice and by adjusting the analyses for socioeconomic and demographic factors. However, residual confounding may still prevail. Yet, the risk of residual confounding should be equally distributed for both patients and comparison subjects, which is likely to lead to an underestimation of the associations.

We restricted the primary intracranial tumor population to first-time cancers only to avoid the influence of potentially increased alertness of health care professionals among patients with a previous history of cancer. This decreased the risk of confounding, but it may also have decreased the generalizability of the study. Surveillance bias may play a role as the patients had more known diseases requiring consultations with medical specialists than the comparison subjects ([Table S2](#SD4-clep-10-809){ref-type="supplementary-material"}). Yet, the results only changed slightly after adjustment for known specialty-specific diseases ([Tables 2](#t2-clep-10-809){ref-type="table"} and [S1](#SD3-clep-10-809){ref-type="supplementary-material"}).

Although the gender-specific analyses and the benign/malignant stratification procedure were used to acknowledge and limit the risk of confounding and selection bias, these analyses and procedures also reduced the statistical precision of the study.

For some of the outcomes, it may be argued that the individual risk of having an increased health care utilization is low, as the absolute difference in proportion is small despite a large relative difference. However, the population-based estimates still indicate possible aspects of clinical practice, which may be optimized at the individual patient level.

Comparison with other studies
-----------------------------

We could not compare our findings directly with other studies of health care use prior to a primary intracranial tumor diagnosis in adults due to the absence of such studies. However, studies in children and young adults with CNS tumors have found increased health care use from 6 and 17 months before diagnosis, respectively.[@b31-clep-10-809],[@b11-clep-10-809] Yet, neither of these studies accounted for differences between benign and malignant tumors. Even so, our findings of increased health care use for patients with benign primary intracranial tumors for up to 2 years before diagnosis indicate that the possibility for an earlier diagnosis in adult patients with benign primary intracranial tumors may be larger than the window of opportunity found in children and young adults with CNS tumors.

Studies of other cancer types have reported increased health care use before a cancer diagnosis with a steep rise from 3 to 6 months prior to diagnosis.[@b32-clep-10-809]--[@b34-clep-10-809] Interestingly, 1 study found an increased health care use up to 2 years prior to diagnosis among lung cancer patients with known chronic obstructive pulmonary disease.[@b35-clep-10-809] In contrast to these studies, we found that patients with malignant primary intracranial tumors only had an increase in health care use relatively close to the time of diagnosis, which indicates lower opportunity for an earlier diagnosis in this group of patients. Studies from the UK have shown that brain tumor patients are more likely to have multiple primary care consultations before referral to hospital[@b12-clep-10-809] and to have long primary care intervals.[@b12-clep-10-809],[@b36-clep-10-809] This may indicate that the symptomatology in patients with a primary intracranial tumor is more nonspecific and vague than in patients with other types of cancers.

In contrast to a Danish study,[@b37-clep-10-809] the primary intracranial tumor patients in our study had almost the same amount of psychiatric contacts than the comparison subjects. Female patients did, however, have significantly increased health care use from 4 months prior to diagnosis for benign tumors and from 2 months prior to diagnosis for malignant tumors; this is in accordance with the findings by Benros et al.[@b37-clep-10-809]

It is well established that many patients with intracranial tumors present with first-time seizures or sudden onset of focal neurological symptoms.[@b7-clep-10-809],[@b38-clep-10-809]--[@b41-clep-10-809] Such emergency presentations could be a marker of diagnostic delay, but it could also simply be related to the nature of intracranial tumors.[@b42-clep-10-809]--[@b44-clep-10-809] Yet, it is ambiguous if these patients have had an initial symptomatic presentation in general practice that did not lead to suspicion of cancer.[@b37-clep-10-809],[@b41-clep-10-809]

As many intracranial tumor patients present as emergencies and as most of the symptoms of intracranial tumors have low predictive values in general practice,[@b8-clep-10-809],[@b45-clep-10-809],[@b46-clep-10-809] only about 1% of adult intracranial tumors are diagnosed following a fast-track GP referral for suspected cancer in the UK.[@b40-clep-10-809] In Denmark, the number of patients detected through the Danish brain Cancer Patient Pathway is unknown, but more than one-third of the patients diagnosed with an intracranial tumor were initially referred on suspicion of other neurological illnesses.[@b45-clep-10-809] Although the Danish brain Cancer Patient Pathway has been found to have acceptable diagnostic work-up time, our study indicates that the diagnosis may be achievable much sooner, as especially patients with a benign tumor have increased health care activity involving several medical specialists many months before diagnosis.

Conclusion
==========

Patients diagnosed with benign and malignant primary intracranial tumors use health care services differently. The increased health care use seen among patients with benign primary intracranial tumors several months prior to diagnosis indicates that there may be a window of opportunity to diagnose these patients several months earlier. In contrast, for patients with malignant primary intracranial tumors, the increased health care use occurred within relatively close proximity to the diagnosis, which indicates lower opportunity for earlier diagnosis in this group of patients.

Future studies should focus on the reasons behind the increased health care use before diagnosis for the patients diagnosed with a benign primary intracranial tumor in order to optimize the diagnostic process.

Supplementary materials
=======================

###### 

Total health care contacts to psychiatry (**A**) and other hospital contacts (**B**) among patients with benign primary intracranial tumors.

**Notes:** Upper parts of **A and B**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A and B**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; IRR, incidence rate ratio; Ref, reference.

###### 

Total health care contacts to psychiatry (**A**) and other hospital contacts (**B**) among patients with malignant primary intracranial tumors.

**Notes:** Upper parts of **A** and **B**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A** and **B**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; IRR, incidence rate ratio; Ref, reference.

###### 

The associations between health care contacts and being diagnosed with a primary intracranial tumor

  Benign tumors                                                                                                                                                                           
  ------------------------------------- ------------------------- --------- ------------ -------------- ------------------------- ------------ ------------ ------ -------- ------ ------ ------------
  ENT                                                                                                                                                                                     
   0                                    1,791                     80.8      19,677       88.8           0.54                      0.48--0.61   1,157        80.5   12,826   89.2   0.52   0.45--0.61
   1--2                                 279                       12.6      1,816        8.2            1.57                      1.36--1.81   177          12.3   1,120    7.8    1.57   1.32--1.88
   ≥3                                   146                       6.6       667          3.0            2.13                      1.74--2.61   104          7.2    434      3.0    2.29   1.79--2.95
  Ophthalmology                                                                                                                                                                           
   0                                    1,684                     76.0      17,717       80             0.82                      0.73--0.91   1,153        80.2   12,210   84.9   0.69   0.60--0.81
   1--2                                 368                       16.6      3,256        14.7           1.12                      0.99--1.27   215          15.0   1,593    11.1   1.44   1.22--1.70
   ≥3                                   164                       7.4       1,187        5.4            1.37                      1.14--1.64   70           4.9    577      4.0    1.22   0.92--1.60
  Neurology                                                                                                                                                                               
   0                                    2,053                     92.6      21,299       96.1           0.58                      0.48--0.71   1,359        94.5   13,842   96.3   0.78   0.59--1.03
   1--2                                 102                       4.6       652          2.9            1.42                      1.12--1.80   59           4.1    395      2.7    1.32   0.98--1.80
   ≥3                                   61                        2.8       209          0.9            2.39                      1.66--3.44   20           1.4    143      1.0    1.14   0.66--1.97
  Psychiatry                                                                                                                                                                              
   0                                    2,137                     96.4      21,444       96.8           1.06                      0.81--1.39   1,394        96.9   14,056   97.7   0.70   0.48--1.01
   1--2                                 19                        0.9       216          1.0            0.72                      0.43--1.21   19           1.3    100      0.7    2.04   1.16--3.57
   ≥3                                   60                        2.7       500          2.3            1.05                      0.77--1.43   25           1.7    224      1.6    1.16   0.72--1.88
                                                                                                                                                                                          
  **Malignant tumors**                                                                                                                                                                    
                                                                                                                                                                                          
  **Number of contacts by specialty**   **Women**                 **Men**                                                                                                                 
  **Patients**                          **Comparison subjects**   **OR**    **95% CI**   **Patients**   **Comparison subjects**   **OR**       **95% CI**                                 
  **n**                                 **%**                     **n**     **%**        **n**          **%**                     **n**        **%**                                      
                                                                                                                                                                                          
  ENT                                                                                                                                                                                     
   0                                    816                       85.8      8,315        87.4           0.92                      0.75--1.13   1,169        88.5   11,641   88.1   1.14   0.94--1.38
   1--2                                 99                        10.4      902          9.5            1.06                      0.84--1.33   103          7.8    1,121    8.5    0.84   0.68--1.05
   ≥3                                   36                        3.8       293          3.1            1.11                      0.75--1.63   49           3.7    448      3.4    0.95   0.68--1.33
  Ophthalmology                                                                                                                                                                           
   0                                    727                       76.4      7,357        77.4           0.92                      0.78--1.08   1,099        83.2   10,924   82.7   1.01   0.87--1.19
   1--2                                 159                       16.7      1,547        16.3           1.05                      0.87--1.26   149          11.3   1,682    12.7   0.90   0.75--1.08
   ≥3                                   65                        6.8       606          6.4            1.18                      0.90--1.56   73           5.5    604      4.6    1.27   0.98--1.66
  Neurology                                                                                                                                                                               
   0                                    903                       95.0      9,123        95.9           0.87                      0.63--1.20   1,253        94.9   12,695   96.1   0.77   0.59--1.02
   1--2                                 30                        3.2       296          3.1            0.82                      0.56--1.21   54           4.1    377      2.9    1.41   1.05--1.91
   ≥3                                   18                        1.9       91           1.0            2.44                      1.42--4.19   14           1.1    138      1.0    0.98   0.55--1.76
  Psychiatry                                                                                                                                                                              
   0                                    922                       97.0      9,225        97.0           0.97                      0.64--1.48   1,297        98.2   12,936   97.9   1.08   0.67--1.74
   1--2                                 7                         0.7       94           1.0            0.72                      0.31--1.71   \<5          --     96       0.7    0.48   0.18--1.31
   ≥3                                   22                        2.3       191          2.0            1.15                      0.70--1.88   20           1.5    178      1.3    1.16   0.67--2.00

**Notes:** OR adjusted for known specialty-specific disease. Adjusted for country of origin, CCI, marital status, income, labor market affiliation, highest educational level, and known specialty-specific disease.

**Abbreviations:** CCI, Charlson Comorbidity Index; CI, confidence interval; ENT, ear--nose--throat; OR, odds ratio.

###### 

Proportion of patients and comparison subjects with known disease 10 years before study entry (before 2 years prior to date of diagnosis/index date)

  Benign tumors                                                                                                                                            
  ------------------------------------------------------------------------------------------ --------------------------- ------------------------- ------- -------
  Headache and migraine[a](#tfn5-clep-10-809){ref-type="table-fn"}                           1.7                         62                        1.2     426
  Epilepsy[b](#tfn6-clep-10-809){ref-type="table-fn"}                                        2.1                         75                        0.9     327
  ENT disease[c](#tfn7-clep-10-809){ref-type="table-fn"}                                     11.4                        417                       7.6     2,789
  Ophthalmologic disease[d](#tfn8-clep-10-809){ref-type="table-fn"}                          12.9                        470                       10.6    3,869
  Neurological disease excluding epilepsy, etc.[e](#tfn9-clep-10-809){ref-type="table-fn"}   9.7                         353                       6.4     2,351
  Psychiatric disease excluding dementia[f](#tfn10-clep-10-809){ref-type="table-fn"}         5.4                         198                       4.4     1,596
  Neurological disease[g](#tfn11-clep-10-809){ref-type="table-fn"}                           11.1                        407                       7.1     2,607
                                                                                                                                                           
  **Malignant tumors**                                                                                                                                     
                                                                                                                                                           
  **Disease category**                                                                       **Patients with disease**   **Comparison subjects**           
  **%**                                                                                      **n**                       **%**                     **n**   
                                                                                                                                                           
  Headache and migraine[a](#tfn5-clep-10-809){ref-type="table-fn"}                           0.5                         11                        0.9     212
  Epilepsy[b](#tfn6-clep-10-809){ref-type="table-fn"}                                        2.0                         45                        0.9     208
  ENT disease[c](#tfn7-clep-10-809){ref-type="table-fn"}                                     11.8                        268                       9.6     2,177
  Ophthalmologic disease[d](#tfn8-clep-10-809){ref-type="table-fn"}                          11.0                        249                       11.7    2,656
  Neurological disease excluding epilepsy, etc.[e](#tfn9-clep-10-809){ref-type="table-fn"}   6.6                         150                       6.5     1,481
  Psychiatric disease excluding dementia[f](#tfn10-clep-10-809){ref-type="table-fn"}         4.3                         97                        4.3     968
  Neurological disease[g](#tfn11-clep-10-809){ref-type="table-fn"}                           8.1                         184                       7.2     1,639

**Notes:**

Headache and migraine (G43;G44);

epilepsy: (G40);

ENT disease: disease in ear and mastoid process of temporal bone (H60-H95);

ophthalmologic disease: diseases in eye and orbital region (H00-H59);

neurological disease (G00-G99) excluding epilepsy, migraine, headache, and neurological disease in the CCI, cerebrovascular disease (G45;G46), hemiplegia (G81;G82), dementia (G30);

psychiatric disease excluding dementia, psychiatric disease, and behavioral disorders (F03-F05.0 and F05.2-F99) excluding F00-F03; F05.1;

neurological disease excluding neurological disease in the CCI.

**Abbreviations:** CCI, Charlson Comorbidity Index; ENT, ear--nose--throat.
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Total health care contacts to GP (daytime) (**A**) physiotherapy (**B**), and radiological examinations (**C**) among patients with benign primary intracranial tumors.

**Notes:** Upper parts of **A--C**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A--C**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; GP, general practitioner; IRR, incidence rate ratio; Ref, reference.
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###### 

Total health care contacts to GP (daytime) (**A**) physiotherapy (**B**), and radiological examinations (**C**) among patients with malignant primary intracranial tumors. **Notes:** Upper parts of **A--C**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A--C**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; GP, general practitioner; IRR, incidence rate ratio; Ref, reference.
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###### 

Total health care contacts to ENT (**A**), ophthalmology (**B**), and neurology (**C**) among patients with benign primary intracranial tumors.

**Notes:** Upper parts of **A--C**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A--C**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; ENT, ear--nose--throat; IRR, incidence rate ratio; Ref, reference.
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###### 

Total health care contacts to ENT (**A**), ophthalmology (**B**), and neurology (**C**) among patients with malignant primary intracranial tumors.

**Notes:** Upper parts of **A--C**: average rates of contacts for patients and comparison subjects 24 months prior to diagnosis/index date. Lower parts of **A--C**: IRRs with 95% CIs.

**Abbreviations:** CI, confidence interval; D, date of diagnosis/index date; ENT, ear--nose--throat; IRR, incidence rate ratio; Ref, reference.
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###### 

Characteristics of the study population of patients with benign or malignant primary intracranial tumors diagnosed in 2009--2014 stratified on gender

  Benign tumors                                                                                                     
  -------------------------- -------- ------ ------- ------ -------- ------ -------- ------ ------- ------ -------- ------
  Age group (years)                                                                                                 
   30--49                    6,090    27.5   609     27.5   6,699    27.5   3,920    27.3   392     27.3   4,312    27.3
   50--69                    10,350   46.7   1,035   46.7   11,385   46.7   7,210    50.1   721     50.1   7,931    50.1
   70--90                    5,720    25.8   572     25.8   6,292    25.8   3,250    22.6   325     22.6   3,575    22.6
  Country of origin                                                                                                 
   Danish                    20,445   92.3   2,058   92.9   22,503   92.3   13,313   92.6   1,342   93.3   14,655   92.6
   Immigrant                 1,715    7.7    158     7.1    1,873    7.7    1,067    7.4    96      6.7    1,163    7.4
  Marital status                                                                                                    
   Cohabiting                13,915   62.8   1,390   62.7   15,305   62.8   10,384   72.2   1,054   73.3   11,438   72.3
   Living alone              8,245    37.2   826     37.3   9,071    37.2   3,996    27.8   384     26.7   4,380    27.7
  Educational level                                                                                                 
   Basic                     7,907    35.7   779     35.2   8,686    35.6   4,255    29.6   428     29.8   4,683    29.6
   Short                     8,069    36.4   814     36.7   8,883    36.4   6,543    45.5   633     44.0   7,176    45.4
   Long                      6,184    27.9   623     28.1   6,807    27.9   3,582    24.9   377     26.2   3,959    25.0
  Labor market affiliation                                                                                          
   Working                   10,453   47.2   992     44.8   11,445   47.0   7,718    53.7   756     52.6   8,474    53.6
   Unemployed                1,384    6.2    153     6.9    1,537    6.3    757      5.3    84      5.8    841      5.3
   Retirement pension        10,323   46.6   1,071   48.3   11,394   46.7   5,905    41.1   598     41.6   6,503    41.1
  Income                                                                                                            
   Low                       7,477    33.7   759     34.3   8,236    33.8   4,132    28.7   416     28.9   4,548    28.8
   Middle                    7,476    33.7   736     33.2   8,212    33.7   4,855    33.8   481     33.4   5,336    33.7
   High                      7,207    32.5   721     32.5   7,928    32.5   5,393    37.5   541     37.6   5,934    37.5
  Comorbidity                                                                                                       
   Low                       18,385   83.0   1,786   80.6   20,171   82.7   11,715   81.5   1,145   79.6   12,860   81.3
   Moderate                  2,486    11.2   274     12.4   2,760    11.3   1,625    11.3   179     12.4   1,804    11.4
   Severe                    1,289    5.8    156     7.0    1,445    5.9    1,040    7.2    114     7.9    1,154    7.3

  Malignant tumors                                                                                              
  -------------------------- ------- ------ ----- ------ ------- ------ -------- ------ ------- ------ -------- ------
  Age group (years)                                                                                             
   30--49                    1,320   13.9   132   13.9   1,452   13.9   2,140    16.2   214     16.2   2,354    16.2
   0--69                     4,690   49.3   469   49.3   5,159   49.3   7,170    54.3   717     54.3   7,887    54.3
   70--90                    3,500   36.8   350   36.8   3,850   36.8   3,900    29.5   390     29.5   4,290    29.5
  Country of origin                                                                                             
   Danish                    8,939   94.0   900   94.6   9,839   94.1   12,379   93.7   1,252   94.8   13,631   93.8
   Immigrant                 571     6.0    51    5.4    622     5.9    831      6.3    69      5.2    900      6.2
  Marital status                                                                                                
   Cohabiting                5,667   59.6   577   60.7   6,244   59.7   9,554    72.3   967     73.2   10,521   72.4
   Living alone              3,843   40.4   374   39.3   4,217   40.3   3,656    27.7   354     26.8   4,010    27.6
  Educational level                                                                                             
   Basic                     3,940   41.4   420   44.2   4,360   41.7   4,255    32.2   424     32.1   4,679    32.2
   Short                     3,299   34.7   325   34.2   3,624   34.6   6,026    45.6   585     44.3   6,611    45.5
   Long                      2,271   23.9   206   21.7   2,477   23.7   2,929    22.2   312     23.6   3,241    22.3
  Labor market affiliation                                                                                      
   Working                   3,341   35.1   328   34.5   3,669   35.1   6,223    47.1   641     48.5   6,864    47.2
   Unemployed                419     4.4    42    4.4    461     4.4    589      4.5    50      3.8    639      4.4
   Retirement pension        5,750   60.5   581   61.1   6,331   60.5   6,398    48.4   630     47.7   7,028    48.4
  Income                                                                                                        
   Low                       3,646   38.3   366   38.5   4,012   38.4   4,191    31.7   374     28.3   4,565    31.4
   Middle                    3,095   32.5   317   33.3   3,412   32.6   4,394    33.3   462     35.0   4,856    33.4
   High                      2,769   29.1   268   28.2   3,037   29.0   4,625    35.0   485     36.7   5,110    35.2
  Comorbidity                                                                                                   
   Low                       7,594   79.9   779   81.9   8,373   80.0   10,306   78.0   1,070   81.0   11,376   78.3
   Moderate                  1,215   12.8   116   12.2   1,331   12.7   1,724    13.1   158     12.0   1,882    13.0
   Severe                    701     7.4    56    5.9    757     7.2    1,180    8.9    93      7.0    1,273    8.8

###### 

The associations (OR) between health care contacts and being diagnosed with a benign or malignant primary intracranial tumor (patients) or not (comparison subjects)

  Benign tumors                                                                                                                                                                           
  ------------------------------------- ------------------------- --------- ------------ -------------- ------------------------- ------------ ------------ ------ -------- ------ ------ --------------
  GP                                                                                                                                                                                      
   0                                    198                       8.9       2,959        13.4           0.65                      0.56--0.76   239          16.6   3,411    23.7   0.64   0.55--0.74
   1--4                                 938                       42.3      10,292       46.4           0.86                      0.78--0.94   704          49.0   6,840    47.6   1.07   0.95--1.19
   5--9                                 691                       31.2      5,858        26.4           1.25                      1.14--1.38   334          23.2   2,721    18.9   1.30   1.14--1.49
   ≥10                                  389                       17.6      3,051        13.8           1.35                      1.20--1.53   161          11.2   1,408    9.8    1.14   0.94--1.37
  Physiotherapy (primary care)                                                                                                                                                            
   0                                    1,903                     85.9      19,467       87.8           0.84                      0.74--0.96   1,308        91.0   13,371   93.0   0.76   0.63--0.92
   1--3                                 60                        2.7       681          3.1            0.89                      0.68--1.16   38           2.6    323      2.2    1.17   0.83--1.65
   ≥4                                   253                       11.4      2,012        9.1            1.28                      1.12--1.47   92           6.4    686      4.8    1.37   1.09--1.72
  Radiology contacts                                                                                                                                                                      
   0                                    1,169                     52.8      13,414       60.5           0.70                      0.64--0.77   948          65.9   10,940   76.1   0.60   0.53--0.67
   1                                    445                       20.1      3,724        16.8           1.27                      1.13--1.44   198          13.8   1,502    10.4   1.36   1.15--1.60
   2                                    204                       9.2       1,834        8.3            1.11                      0.95--1.29   123          8.6    760      5.3    1.68   1.37--2.05
   ≥3                                   398                       18.0      3,188        14.4           1.29                      1.14--1.45   169          11.8   1,178    8.2    1.51   1.26--1.80
  ENT                                                                                                                                                                                     
   0                                    1,791                     80.8      19,677       88.8           0.52                      0.47--0.59   1,157        80.5   12,826   89.2   0.49   0.42--0.57
   1--2                                 279                       12.6      1,816        8.2            1.63                      1.42--1.87   177          12.3   1,120    7.8    1.67   1.41--1.98
   ≥3                                   146                       6.6       667          3.0            2.28                      1.89--2.76   104          7.2    434      3.0    2.52   2.01--3.16
  Ophthalmology                                                                                                                                                                           
   0                                    1,684                     76.0      17,717       80             0.79                      0.71--0.88   1,153        80.2   12,210   84.9   0.69   0.60--0.81
   1--2                                 368                       16.6      3,256        14.7           1.15                      1.01--1.30   215          15.0   1,593    11.1   1.45   1.23--1.70
   ≥3                                   164                       7.4       1,187        5.4            1.42                      1.19--1.70   70           4.9    577      4.0    1.21   0.93--1.58
  Neurology                                                                                                                                                                               
   0                                    2,053                     92.6      21,299       96.1           0.53                      0.45--0.64   1,359        94.5   13,842   96.3   0.68   0.53--0.87
   1--2                                 102                       4.6       652          2.9            1.53                      1.22--1.90   59           4.1    395      2.7    1.47   1.11--1.96
   ≥3                                   61                        2.8       209          0.9            2.74                      2.01--3.74   20           1.4    143      1.0    1.51   0.94--2.43
  Psychiatry                                                                                                                                                                              
   0                                    2,137                     96.4      21,444       96.8           1.00                      0.78--1.29   1,394        96.9   14,056   97.7   0.71   0.48--1.03
   1--2                                 19                        0.9       216          1.0            0.74                      0.44--1.22   19           1.3    100      0.7    1.91   1.07--3.39
   ≥3                                   60                        2.7       500          2.3            1.12                      0.83--1.51   25           1.7    224      1.6    1.20   0.74--1.93
  Other hospital specialties                                                                                                                                                              
   0                                    1,205                     54.4      13,985       63.1           0.70                      0.64--0.77   837          58.2   9,697    67.4   0.67   0.59--0.75
   1--2                                 499                       22.5      4,054        18.3           1.29                      1.16--1.44   300          20.9   2,580    17.9   1.20   1.04--1.37
   ≥3                                   512                       23.1      4,121        18.6           1.29                      1.16--1.44   301          20.9   2,103    14.6   1.57   1.37--1.81
                                                                                                                                                                                          
  **Malignant tumors**                                                                                                                                                                    
  **Number of contacts by specialty**   **Women**                 **Men**                                                                                                                 
  **Patients**                          **Comparison subjects**   **OR**    **95% CI**   **Patients**   **Comparison subjects**   **OR**       **95% CI**                                 
  **n**                                 **%**                     **n**     **%**        **n**          **%**                     **n**        **%**                                      
                                                                                                                                                                                          
  GP                                                                                                                                                                                      
   0                                    123                       12.9      1,222        12.8           1.00                      0.81--1.23   293          22.2   2,836    21.5   1.03   0.89--1.19
   1--4                                 427                       44.9      4,241        44.6           1.01                      0.88--1.16   607          46.0   6,022    45.6   0.99   0.88--1.12
   5--9                                 271                       28.5      2,619        27.5           1.05                      0.91--1.22   295          22.3   2,819    21.3   1.09   0.95--1.26
   ≥10                                  130                       13.7      1,428        15.0           0.90                      0.74--1.11   126          9.5    1,533    11.6   0.85   0.70--1.05
  Physiotherapy (primary care)                                                                                                                                                            
   0                                    823                       86.5      8,346        87.8           0.88                      0.72--1.08   1,226        92.8   12,295   93.1   0.98   0.79--1.22
   1--3                                 28                        2.9       257          2.7            1.12                      0.75--1.68   31           2.3    267      2.0    1.13   0.77--1.66
   ≥4                                   100                       10.5      907          9.5            1.13                      0.90--1.41   64           4.8    648      4.9    0.97   0.75--1.26
  Radiology contacts                                                                                                                                                                      
   0                                    580                       61.0      5,794        60.9           0.99                      0.85--1.14   973          73.7   9,756    73.9   0.95   0.83--1.09
   1                                    155                       16.3      1,550        16.3           1.01                      0.83--1.22   157          11.9   1,469    11.1   1.08   0.91--1.29
   2                                    73                        7.7       857          9.0            0.84                      0.65--1.08   74           5.6    749      5.7    1.00   0.78--1.29
   ≥3                                   143                       15.0      1,309        13.8           1.15                      0.95--1.40   117          8.9    1,236    9.4    1.01   0.82--1.25
  ENT                                                                                                                                                                                     
   0                                    816                       85.8      8,315        87.4           0.87                      0.71--1.06   1,169        88.5   11,641   88.1   1.04   0.87--1.24
   1--2                                 99                        10.4      902          9.5            1.11                      0.89--1.39   103          7.8    1,121    8.5    0.91   0.73--1.12
   ≥3                                   36                        3.8       293          3.1            1.25                      0.87--1.79   49           3.7    448      3.4    1.12   0.82--1.52
  Ophthalmology                                                                                                                                                                           
   0                                    727                       76.4      7,357        77.4           0.94                      0.80--1.11   1,099        83.2   10,924   82.7   1.01   0.86--1.18
   1--2                                 159                       16.7      1,547        16.3           1.04                      0.87--1.25   149          11.3   1,682    12.7   0.90   0.75--1.08
   ≥3                                   65                        6.8       606          6.4            1.09                      0.83--1.43   73           5.5    604      4.6    1.23   0.95--1.59
  Neurology                                                                                                                                                                               
   0                                    903                       95.0      9,123        95.9           0.81                      0.60--1.10   1,253        94.9   12,695   96.1   0.72   0.55--0.94
   1--2                                 30                        3.2       296          3.1            0.96                      0.66--1.39   54           4.1    377      2.9    1.51   1.12-- −2.03
   ≥3                                   18                        1.9       91           1.0            2.00                      1.19--3.34   14           1.1    138      1.0    1.08   0.62--1.89
  Psychiatry                                                                                                                                                                              
   0                                    922                       97.0      9,225        97             0.94                      0.63--1.40   1,297        98.2   12,936   97.9   1.03   0.66--1.59
   1--2                                 7                         0.7       94           1.0            0.71                      0.31--1.61   \<5          --     96       0.7    0.49   0.18--1.28
   ≥3                                   22                        2.3       191          2.0            1.25                      0.80--1.95   20           1.5    178      1.3    1.24   0.75--2.04
  Other hospital specialties                                                                                                                                                              
   0                                    621                       65.3      5,959        62.7           1.09                      0.94--1.27   881          66.7   8,673    65.7   1.00   0.88--1.13
   1--2                                 164                       17.2      1,755        18.5           0.93                      0.78--1.11   227          17.2   2,308    17.5   0.99   0.85--1.15
   ≥3                                   166                       17.5      1,796        18.9           0.95                      0.79--1.14   213          16.1   2,229    16.9   1.03   0.87--1.21

**Notes:** Adjusted for country of origin, CCI, marital status, income, labor market affiliation, highest educational level.

**Abbreviations:** CCI, Charlson Comorbidity Index; CI, confidence interval; ENT, ear--nose --throat; GP, general practitioner; OR, odds ratio.
